V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002585 | 210002585 | null | null | null | null | 2019-10-20 | ROSCO Trial | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100680230 |
| 210002591 | 210002591 | 1.57 | null | null | null | 2016-02-29 | Capecitabine | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100810001 |
| 210002611 | 210002611 | null | null | null | 2017-04-20 | 2017-04-20 | EC | null | null | TRIAL | 101516640 |
| 210002648 | 210002648 | null | null | null | 2018-05-28 | 2018-05-28 | PACLITAXEL | 01 | N | EC | 101843835 |
| 210002649 | 210002649 | 1.74 | 61.9 | null | null | 2018-01-19 | EC | 02 | N | CMF | 100533627 |
| 210002650 | 210002650 | null | null | null | null | 2016-09-01 | FEC 100 | 02 | N | CARBOPLATIN | 100570355 |
| 210002652 | 210002652 | null | null | Adjuvant (A) | 2019-05-29 | 2019-06-11 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101398824 |
| 210002669 | 210002669 | null | null | null | 2018-12-12 | 2018-12-16 | FEC | N | N | ERIBULIN | 101746297 |
| 210002698 | 210002698 | null | null | null | 2017-06-02 | 2017-06-25 | TCH (21 day Trastuzumab) Maint | 02 | N | FEC | 100824686 |
| 210002711 | 210002711 | null | null | null | null | 2016-02-29 | Cisplatin + Pemetrexed | null | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 100873272 |
| 210002717 | 210002717 | null | null | null | 2019-01-06 | 2019-01-14 | EC | 2 | N | FEC + DOCETAXEL | 101177175 |
| 210002730 | 210002730 | null | null | null | null | 2017-11-04 | Abemaciclib | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101276214 |
| 210002731 | 210002731 | null | null | null | 2018-04-30 | 2018-04-30 | FEC + TRASTUZUMAB | 02 | N | TAC | 100380953 |
| 210002734 | 210002734 | null | null | null | 2018-05-30 | 2018-05-30 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101390420 |
| 210002739 | 210002739 | null | null | null | null | 2018-05-23 | FEC | 02 | N | CARBOPLATIN | 101563599 |
| 210002743 | 210002743 | null | null | null | null | 2017-05-30 | null | null | null | EC | 101188165 |
| 210002764 | 210002764 | null | null | null | null | 2018-10-26 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 100270661 |
| 210002798 | 210002798 | null | null | null | 2019-02-05 | 2019-02-17 | EC + PACLITAXEL | 02 | null | FEC | 101664851 |
| 210002814 | 210002814 | null | null | null | null | 2019-05-01 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100113689 |
| 210002867 | 210002867 | null | null | null | 2018-05-20 | 2018-06-06 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | null | EC | 100232881 |
| 210002869 | 210002869 | null | null | null | null | 2019-08-08 | CARBOPLATIN + PACLITAXEL | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101557634 |
| 210002890 | 210002890 | null | null | null | null | 2016-02-17 | OCTREOTIDE | null | null | CARBOPLATIN + GEMCITABINE | 100921578 |
| 210002905 | 210002905 | null | null | null | null | 2017-06-11 | FEC + DOCETAXEL | 02 | null | EC | 101028049 |
| 210002910 | 210002910 | null | null | null | null | 2018-07-11 | EC | null | null | FEC | 100774139 |
| 210002911 | 210002911 | null | null | Neo-adjuvant (N) | null | 2016-07-09 | FEC 100 | null | null | CARBOPLATIN | 101261700 |
| 210002932 | 210002932 | 1.66 | 87 | null | null | 2016-03-15 | Everolimus 10mg | null | N | PACLITAXEL | 100613122 |
| 210002942 | 210002942 | null | 80.4 | null | null | 2017-03-03 | Cyclophosphamide + Docetaxel | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101053988 |
| 210002958 | 210002958 | null | null | null | 2017-05-11 | 2017-05-25 | null | 02 | N | CARBOPLATIN | 101418076 |
| 210002965 | 210002965 | 1.61 | 114.6 | null | null | 2015-10-12 | FEC 100 | null | N | FEC + DOCETAXEL | 100667877 |
| 210003006 | 210003006 | 1.69 | 47.8 | null | null | 2018-11-03 | FEC + DOCETAXEL | 02 | N | STAKT TRIAL | 100469150 |
| 210003018 | 210003018 | null | null | null | null | 2019-03-19 | FEC 100 + DOCETAXEL | 02 | N | CAPECITABINE | 100464647 |
| 210003021 | 210003021 | null | null | null | 2019-06-27 | 2019-07-09 | ROSCO Trial | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101517375 |
| 210003027 | 210003027 | null | null | null | 2018-10-01 | 2018-10-03 | null | 2 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101389681 |
| 210003070 | 210003070 | null | null | null | 2018-10-15 | 2018-11-14 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100030471 |
| 210003092 | 210003092 | null | null | null | 2018-08-30 | 2018-09-14 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101342059 |
| 210003105 | 210003105 | null | null | null | null | 2017-07-19 | Paclitaxel 7 day | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100718817 |
| 210003121 | 210003121 | null | null | null | null | 2019-02-07 | Carboplatin AUC 2 - 5 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100552009 |
| 210003127 | 210003127 | null | null | null | 2018-08-16 | 2018-09-05 | AC | 2 | N | DOCETAXEL + TRASTUZUMAB | 100351543 |
| 210003149 | 210003149 | null | null | null | null | 2016-06-21 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101333903 |
| 210003156 | 210003156 | 1.61 | 60 | null | null | 2019-02-04 | FEC 100 | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100730190 |
| 210003182 | 210003182 | 1.75 | 70.6 | Neo-adjuvant (N) | null | 2017-01-28 | FEC + TRASTUZUMAB | null | N | CAPECITABINE | 100777017 |
| 210003198 | 210003198 | null | null | null | 2019-04-12 | 2019-04-15 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100971421 |
| 210003232 | 210003232 | 1.55 | 104.4 | null | null | 2018-07-08 | FEC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100731432 |
| 210003297 | 210003297 | 1.76 | 76.6 | null | 2018-07-31 | 2018-08-03 | FEC 100 + DOCETAXEL | 02 | N | DOCETAXEL | 101440982 |
| 210003305 | 210003305 | null | null | null | 2019-06-27 | 2019-06-27 | null | 01 | Y | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100432458 |
| 210003331 | 210003331 | null | null | null | 2018-09-16 | 2018-09-16 | Docetaxel | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101718877 |
| 210003333 | 210003333 | null | null | null | 2019-09-21 | 2019-09-21 | Cisplatin + Etoposide po&iv 3 day | N | N | CARBOPLATIN | 100273998 |
| 210003359 | 210003359 | null | null | Adjuvant (A) | null | 2012-10-26 | EC | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101038709 |
| 210003407 | 210003407 | null | null | null | 2019-02-18 | 2019-02-19 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101465817 |
| 210003412 | 210003412 | null | 93.7 | null | 2015-06-27 | 2015-07-03 | Docetaxel | 02 | N | TRIAL | 101673507 |